In The News
Judge trims funder’s cut in $38M Mayne Pharma class action settlement
New Zealand’s highest court endorses early common fund orders
Chartered Accountants drops investigation into ex-PwC tax partner
Virbac loses bid to block generic animal drug
Babcock & Brown shareholders can’t stay costs orders in failed 10-year-old case
Law firm can’t dodge $5.4M security in Macquarie class action
‘Truly lamentable’: Solicitors score partial win in tax appeal
Pfizer faces class action investigation into Depo-Provera
IP firm loses challenge to Apple’s authentication patent
ASIC can bring case against Rex Airlines, directors
Please login to bookmarkClose

US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au